Form 4: Phreesia SVP David Linetsky Reports Stock Sales to Cover Tax Obligations

David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported the sale of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• David Linetsky, SVP of Life Sciences at Phreesia, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On March 18, 2025, Linetsky disposed of 39 shares of common stock at a weighted average price of $26.9507 per share.
• On March 19, 2025, Linetsky disposed of 81 shares of common stock at a weighted average price of $27.8479 per share.
• Also on March 19, 2025, Linetsky disposed of 7 shares of common stock at a weighted average price of $28.3112 per share.
• These sales were non-discretionary transactions to cover tax withholding obligations related to the settlement of restricted stock units.
• Following these transactions, Linetsky directly owns 218,135 shares and indirectly owns 8,724 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning or tax obligations. The disclosure provides transparency into the transactions of company insiders.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

Keywords

Form 4, Phreesia, Linetsky, Stock Sale, Beneficial Ownership, Tax Obligations, Restricted Stock Units